Gaps in the drug-free and methadone treatment program response to Hepatitis C. (Q47754839)

5 February 2018

title

Gaps in the drug-free and methadone treatment program response to Hepatitis C. (English)

1 reference

5 February 2018

author

Shiela M Strauss

1

1 reference

5 February 2018

Don C Des Jarlais

4

object named as

Don C Des Jarlais

1 reference

5 February 2018

author name string

Janetta Astone

2

1 reference

5 February 2018

Zdravko P Vassilev

3

1 reference

5 February 2018

Holly Hagan

5

1 reference

5 February 2018

publication date

1 June 2003

1 reference

5 February 2018

Journal of Substance Abuse Treatment

published in

1 reference

5 February 2018

volume

24

1 reference

5 February 2018

issue

4

1 reference

5 February 2018

page(s)

291-297

1 reference

5 February 2018

Accuracy of perceptions of hepatitis B and C status: cross sectional investigation of opiate addicts in treatment

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900037-0

7 January 2021

Health care need and utilization: a preliminary comparison of injection drug users, other illicit drug users, and nonusers

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900037-0

7 January 2021

Organizational factors related to AIDS/HIV education in outpatient substance abuse treatment units

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900037-0

7 January 2021

Supervisor ideology and organizational response: HIV/AIDS prevention in outpatient substance abuse treatment units

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900037-0

7 January 2021

Current management of infectious complications in the injecting drug user

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900037-0

7 January 2021

An organizational analysis of service patterns in outpatient drug abuse treatment units

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900037-0

7 January 2021

Survey of hepatitis B and C in addiction treatment unit.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900037-0

7 January 2021

On-site primary care and mental health services in outpatient drug abuse treatment units

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900037-0

7 January 2021

Delivery of HIV risk-reduction services in drug treatment programs

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900037-0

7 January 2021

Syringe exchange and risk of infection with hepatitis B and C viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900037-0

7 January 2021

Sharing of drug preparation equipment as a risk factor for hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900037-0

7 January 2021

Hepatitis C virus: epidemiology and transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900037-0

7 January 2021

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900037-0

7 January 2021

Drug-user treatment programs in a large metropolitan area

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900037-0

7 January 2021

Hepatitis C screening and management practices: a survey of drug treatment and syringe exchange programs in New York City

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900037-0

7 January 2021

Natural history of hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900037-0

7 January 2021

Incidence and prevalence of hepatitis C among clients of a Brisbane methadone clinic: factors influencing hepatitis C serostatus

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900037-0

7 January 2021

Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900037-0

7 January 2021

Hepatitis C disease among injection drug users: knowledge, perceived risk and willingness to receive treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900037-0

7 January 2021

A nationwide survey of hepatitis C services provided by drug treatment programs

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900037-0

7 January 2021

Correlates of hepatitis C virus infections among injection drug users.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900037-0

7 January 2021

Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in Amsterdam.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900037-0

7 January 2021

Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900037-0

7 January 2021

National survey of hepatitis testing and vaccination services provided by drug services in England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900037-0

7 January 2021

Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2803%2900037-0

7 January 2021

10.1016/S0740-5472(03)00037-0

Identifiers

DOI

1 reference

5 February 2018

release_be3f6moj2fdevbv46ck5aprzvq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/be3f6moj2fdevbv46ck5aprzvq

24 November 2022

mapped directly with Wikidata item

1 reference

5 February 2018